PARKINSON'S DISEASE

Fluofarma set up a toolbox to support drug discovery projects targeting Parkinson's disease and related disorders. On one hand, we offer to identify and characterize neuroprotective compounds in predictive in vitro models of Parkinson's disease, based on primary neuronal cultures. On the other hand, we developed capacities for the assessment of in vivo drug efficacy and mechanism of action, combining behavioral tests and automated tissue imaging.

BRAIN TISSUES ANALYSIS

Following behavioral and cognitive tests, we offer to analyze brain tissues at the single-cell level using automated tissue imaging, so as to understand the molecular underpinnings of compounds' effects: